The role of procoagulants and anticoagulants in the development of venous thromboembolism

Abstract Procoagulant and anticoagulant reactions play an important role in the regulation of thrombin formation during secondary hemostasis. Three phases can be recognized in the kinetics of thrombin formation: an initiation phase, a propagation phase and a termination phase. Dysregulation of throm...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Thrombosis research 2009, Vol.123, p.S41-S45
1. Verfasser: Bertina, Rogier M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page S45
container_issue
container_start_page S41
container_title Thrombosis research
container_volume 123
creator Bertina, Rogier M
description Abstract Procoagulant and anticoagulant reactions play an important role in the regulation of thrombin formation during secondary hemostasis. Three phases can be recognized in the kinetics of thrombin formation: an initiation phase, a propagation phase and a termination phase. Dysregulation of thrombin formation during each of these phases by (hereditary) changes in the plasma concentration of pro- and anticoagulants contributes to the development of venous thrombosis. Most important seems the defective down-regulation of the prothrombinase activity during the termination phase. Procoagulant and anticoagulant proteins have important roles in the regulation of fibrin formation during secondary hemostasis. Under normal physiological conditions there is a delicate balance between the procoagulant and anticoagulant reactions. After damage to the vessel wall sufficient fibrin is formed to arrest bleeding and allow repair of the lesion without obstructing blood circulation. Venous thrombosis can be considered as a hemostatic process getting out of control, where massive fibrin formation has resulted in the formation of an obstructive thrombus. Such thrombus formation is believed to be facilitated by changes in the vessel wall, blood flow and the composition of the blood. During the past 50 years substantial progress has been made in our understanding of the enzymatic reactions involved in the hemostatic process. At the same time information has been obtained on particular changes in the composition of the blood which contribute to the development of venous thrombosis. Most of these changes concern the procoagulant and anticoagulant systems. In this paper I will briefly discuss how fibrin formation is regulated by procoagulant and anticoagulant reactions and how certain changes in these pathways contribute to the development of venous thrombosis.
doi_str_mv 10.1016/S0049-3848(09)70142-2
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67052503</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0049384809701422</els_id><sourcerecordid>67052503</sourcerecordid><originalsourceid>FETCH-LOGICAL-c418t-ff799eed9a0b682b9efa7b24ff60777c691c67b422b1c92cb7195ff093818fbd3</originalsourceid><addsrcrecordid>eNqFUE1L7DAUDaLo-PETlK5EF9WbtNM0mycy-AWCC3XhKjTpjcbXNvOSdsB_bzoz6MONi0sg95xzzzmEHFI4o0CL80eAXKRZmZcnIE450JylbINMaMlFynLONsnkC7JDdkN4B6Cciuk22aEig2wK2YS8PL1h4l2DiTPJ3Dvtqtehqbo-JFVXx-ntf1-2S_qIr3GBjZu32PUjbYGdG0LceNcqh3EaG9p9smWqJuDB-t0jz9dXT7Pb9P7h5m52eZ_qnJZ9agwXArEWFaiiZEqgqbhiuTEFcM51IaguuMoZU1QLptUYwRgQWUlLo-psjxyvdKP7fwOGXrY2aGyiY4y2ZMFhymLWCJyugNq7EDwaOfe2rfyHpCDHTuWyUzkWJkHIZaeSRd7R-sCgWqy_WesSI-BiBcAYc2HRy6Atdhpr61H3snb21xN_fijoxnZWV81f_MDw7gbfxQ4llYFJWImMGiCWCiz7BBegnMM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67052503</pqid></control><display><type>article</type><title>The role of procoagulants and anticoagulants in the development of venous thromboembolism</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Bertina, Rogier M</creator><creatorcontrib>Bertina, Rogier M</creatorcontrib><description>Abstract Procoagulant and anticoagulant reactions play an important role in the regulation of thrombin formation during secondary hemostasis. Three phases can be recognized in the kinetics of thrombin formation: an initiation phase, a propagation phase and a termination phase. Dysregulation of thrombin formation during each of these phases by (hereditary) changes in the plasma concentration of pro- and anticoagulants contributes to the development of venous thrombosis. Most important seems the defective down-regulation of the prothrombinase activity during the termination phase. Procoagulant and anticoagulant proteins have important roles in the regulation of fibrin formation during secondary hemostasis. Under normal physiological conditions there is a delicate balance between the procoagulant and anticoagulant reactions. After damage to the vessel wall sufficient fibrin is formed to arrest bleeding and allow repair of the lesion without obstructing blood circulation. Venous thrombosis can be considered as a hemostatic process getting out of control, where massive fibrin formation has resulted in the formation of an obstructive thrombus. Such thrombus formation is believed to be facilitated by changes in the vessel wall, blood flow and the composition of the blood. During the past 50 years substantial progress has been made in our understanding of the enzymatic reactions involved in the hemostatic process. At the same time information has been obtained on particular changes in the composition of the blood which contribute to the development of venous thrombosis. Most of these changes concern the procoagulant and anticoagulant systems. In this paper I will briefly discuss how fibrin formation is regulated by procoagulant and anticoagulant reactions and how certain changes in these pathways contribute to the development of venous thrombosis.</description><identifier>ISSN: 0049-3848</identifier><identifier>EISSN: 1879-2472</identifier><identifier>DOI: 10.1016/S0049-3848(09)70142-2</identifier><identifier>PMID: 19303503</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Animals ; Anticoagulants ; Blood Coagulation ; Blood Coagulation Factor Inhibitors - blood ; Blood Coagulation Factors - metabolism ; Fibrin - metabolism ; Hematology, Oncology and Palliative Medicine ; Humans ; Kinetics ; Procoagulants ; Risk Factors ; Thrombin - metabolism ; Thromboplastin - metabolism ; Venous Thromboembolism - blood ; Venous Thromboembolism - etiology ; Venous thrombosis</subject><ispartof>Thrombosis research, 2009, Vol.123, p.S41-S45</ispartof><rights>Elsevier Ltd</rights><rights>2009 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c418t-ff799eed9a0b682b9efa7b24ff60777c691c67b422b1c92cb7195ff093818fbd3</citedby><cites>FETCH-LOGICAL-c418t-ff799eed9a0b682b9efa7b24ff60777c691c67b422b1c92cb7195ff093818fbd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0049-3848(09)70142-2$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,4024,27923,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19303503$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bertina, Rogier M</creatorcontrib><title>The role of procoagulants and anticoagulants in the development of venous thromboembolism</title><title>Thrombosis research</title><addtitle>Thromb Res</addtitle><description>Abstract Procoagulant and anticoagulant reactions play an important role in the regulation of thrombin formation during secondary hemostasis. Three phases can be recognized in the kinetics of thrombin formation: an initiation phase, a propagation phase and a termination phase. Dysregulation of thrombin formation during each of these phases by (hereditary) changes in the plasma concentration of pro- and anticoagulants contributes to the development of venous thrombosis. Most important seems the defective down-regulation of the prothrombinase activity during the termination phase. Procoagulant and anticoagulant proteins have important roles in the regulation of fibrin formation during secondary hemostasis. Under normal physiological conditions there is a delicate balance between the procoagulant and anticoagulant reactions. After damage to the vessel wall sufficient fibrin is formed to arrest bleeding and allow repair of the lesion without obstructing blood circulation. Venous thrombosis can be considered as a hemostatic process getting out of control, where massive fibrin formation has resulted in the formation of an obstructive thrombus. Such thrombus formation is believed to be facilitated by changes in the vessel wall, blood flow and the composition of the blood. During the past 50 years substantial progress has been made in our understanding of the enzymatic reactions involved in the hemostatic process. At the same time information has been obtained on particular changes in the composition of the blood which contribute to the development of venous thrombosis. Most of these changes concern the procoagulant and anticoagulant systems. In this paper I will briefly discuss how fibrin formation is regulated by procoagulant and anticoagulant reactions and how certain changes in these pathways contribute to the development of venous thrombosis.</description><subject>Animals</subject><subject>Anticoagulants</subject><subject>Blood Coagulation</subject><subject>Blood Coagulation Factor Inhibitors - blood</subject><subject>Blood Coagulation Factors - metabolism</subject><subject>Fibrin - metabolism</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Kinetics</subject><subject>Procoagulants</subject><subject>Risk Factors</subject><subject>Thrombin - metabolism</subject><subject>Thromboplastin - metabolism</subject><subject>Venous Thromboembolism - blood</subject><subject>Venous Thromboembolism - etiology</subject><subject>Venous thrombosis</subject><issn>0049-3848</issn><issn>1879-2472</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUE1L7DAUDaLo-PETlK5EF9WbtNM0mycy-AWCC3XhKjTpjcbXNvOSdsB_bzoz6MONi0sg95xzzzmEHFI4o0CL80eAXKRZmZcnIE450JylbINMaMlFynLONsnkC7JDdkN4B6Cciuk22aEig2wK2YS8PL1h4l2DiTPJ3Dvtqtehqbo-JFVXx-ntf1-2S_qIr3GBjZu32PUjbYGdG0LceNcqh3EaG9p9smWqJuDB-t0jz9dXT7Pb9P7h5m52eZ_qnJZ9agwXArEWFaiiZEqgqbhiuTEFcM51IaguuMoZU1QLptUYwRgQWUlLo-psjxyvdKP7fwOGXrY2aGyiY4y2ZMFhymLWCJyugNq7EDwaOfe2rfyHpCDHTuWyUzkWJkHIZaeSRd7R-sCgWqy_WesSI-BiBcAYc2HRy6Atdhpr61H3snb21xN_fijoxnZWV81f_MDw7gbfxQ4llYFJWImMGiCWCiz7BBegnMM</recordid><startdate>2009</startdate><enddate>2009</enddate><creator>Bertina, Rogier M</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2009</creationdate><title>The role of procoagulants and anticoagulants in the development of venous thromboembolism</title><author>Bertina, Rogier M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c418t-ff799eed9a0b682b9efa7b24ff60777c691c67b422b1c92cb7195ff093818fbd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Animals</topic><topic>Anticoagulants</topic><topic>Blood Coagulation</topic><topic>Blood Coagulation Factor Inhibitors - blood</topic><topic>Blood Coagulation Factors - metabolism</topic><topic>Fibrin - metabolism</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Kinetics</topic><topic>Procoagulants</topic><topic>Risk Factors</topic><topic>Thrombin - metabolism</topic><topic>Thromboplastin - metabolism</topic><topic>Venous Thromboembolism - blood</topic><topic>Venous Thromboembolism - etiology</topic><topic>Venous thrombosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bertina, Rogier M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Thrombosis research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bertina, Rogier M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The role of procoagulants and anticoagulants in the development of venous thromboembolism</atitle><jtitle>Thrombosis research</jtitle><addtitle>Thromb Res</addtitle><date>2009</date><risdate>2009</risdate><volume>123</volume><spage>S41</spage><epage>S45</epage><pages>S41-S45</pages><issn>0049-3848</issn><eissn>1879-2472</eissn><abstract>Abstract Procoagulant and anticoagulant reactions play an important role in the regulation of thrombin formation during secondary hemostasis. Three phases can be recognized in the kinetics of thrombin formation: an initiation phase, a propagation phase and a termination phase. Dysregulation of thrombin formation during each of these phases by (hereditary) changes in the plasma concentration of pro- and anticoagulants contributes to the development of venous thrombosis. Most important seems the defective down-regulation of the prothrombinase activity during the termination phase. Procoagulant and anticoagulant proteins have important roles in the regulation of fibrin formation during secondary hemostasis. Under normal physiological conditions there is a delicate balance between the procoagulant and anticoagulant reactions. After damage to the vessel wall sufficient fibrin is formed to arrest bleeding and allow repair of the lesion without obstructing blood circulation. Venous thrombosis can be considered as a hemostatic process getting out of control, where massive fibrin formation has resulted in the formation of an obstructive thrombus. Such thrombus formation is believed to be facilitated by changes in the vessel wall, blood flow and the composition of the blood. During the past 50 years substantial progress has been made in our understanding of the enzymatic reactions involved in the hemostatic process. At the same time information has been obtained on particular changes in the composition of the blood which contribute to the development of venous thrombosis. Most of these changes concern the procoagulant and anticoagulant systems. In this paper I will briefly discuss how fibrin formation is regulated by procoagulant and anticoagulant reactions and how certain changes in these pathways contribute to the development of venous thrombosis.</abstract><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>19303503</pmid><doi>10.1016/S0049-3848(09)70142-2</doi></addata></record>
fulltext fulltext
identifier ISSN: 0049-3848
ispartof Thrombosis research, 2009, Vol.123, p.S41-S45
issn 0049-3848
1879-2472
language eng
recordid cdi_proquest_miscellaneous_67052503
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Animals
Anticoagulants
Blood Coagulation
Blood Coagulation Factor Inhibitors - blood
Blood Coagulation Factors - metabolism
Fibrin - metabolism
Hematology, Oncology and Palliative Medicine
Humans
Kinetics
Procoagulants
Risk Factors
Thrombin - metabolism
Thromboplastin - metabolism
Venous Thromboembolism - blood
Venous Thromboembolism - etiology
Venous thrombosis
title The role of procoagulants and anticoagulants in the development of venous thromboembolism
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T16%3A39%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20role%20of%20procoagulants%20and%20anticoagulants%20in%20the%20development%20of%20venous%20thromboembolism&rft.jtitle=Thrombosis%20research&rft.au=Bertina,%20Rogier%20M&rft.date=2009&rft.volume=123&rft.spage=S41&rft.epage=S45&rft.pages=S41-S45&rft.issn=0049-3848&rft.eissn=1879-2472&rft_id=info:doi/10.1016/S0049-3848(09)70142-2&rft_dat=%3Cproquest_cross%3E67052503%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67052503&rft_id=info:pmid/19303503&rft_els_id=1_s2_0_S0049384809701422&rfr_iscdi=true